Domestic cats (Felis catus) develop the same patterns of brain shrinkage and neurological decline as aging humans, and scientists think that makes them an ideal window into dementia and aging.
The post Domestic Cats Age Like Humans, New Study Shows appeared first on Sci.News: Breaking Science News.
The same neural system handled English, Spanish and even invented words.Recent breakthroughs in neuropsychiatric research have brought to light remarkable insights into the molecular underpinnings of bipolar disorder (BD) and major depressive disorder (MDD), two of the most debilitating mood disorders worldwide. In an ambitious study published in Translational Psychiatry, Gao, Otsuka, Shirai, and colleagues harnessed the power of postmortem brain tissue analysis, combining single-nucleus RNA sequencing with traditional bulk gene expression techniques. Their pioneering work revealed intricate shared and distinct neuropathological alterations between these disorders, carving a new path for understanding their complex biology on an unprecedented scale.
Bipolar disorder and major depressive disorder are notoriously challenging to differentiate clinically, with overlapping symptoms but divergent treatment responses, underscoring the urgent need for molecular markers that delineate their neurobiological distinctions and commonalities. The investigators obtained postmortem brain specimens from multiple brain regions critically involved in mood regulation, including the prefrontal cortex and hippocampus, to delineate cell-type-specific transcriptomic changes that contribute to these psychiatric conditions.
A key innovation in this study was the utilization of single-nucleus RNA sequencing, a cutting-edge technique that isolates nuclei from archived frozen brain tissue, enabling fine-grained analysis of gene expression at single-cell resolution. This approach circumvents the issue of cellular heterogeneity within bulk tissue samples, revealing how discrete neuronal and glial populations are differentially affected in BD and MDD. By integrating single-nucleus and bulk RNA-seq data, the research team robustly characterized both cell-type-specific expression patterns and more global transcriptomic signatures associated with mood disorders.
The results illuminated both convergent and divergent pathological processes. For instance, inflammatory responses and synaptic signaling pathways were dysregulated across both BD and MDD, suggesting common neuroimmune mechanisms contributing to mood dysregulation. However, certain pathways, such as mitochondrial function and calcium signaling, exhibited distinct alterations exclusive to bipolar disorder, potentially explaining its episodic mood swings and treatment resistance. Conversely, dysregulation in neuroplasticity-related genes was more prominent in major depressive disorder, providing molecular evidence for the chronic and often treatment-resistant nature of depressive states.
In particular, inhibitory interneurons, which play a pivotal role in maintaining excitatory/inhibitory balance within cortical circuits, showed altered gene expression profiles predominantly in the bipolar disorder samples. These perturbations may underlie the episodic manic and depressive phases characteristic of BD, by disrupting cortical oscillations and neuronal synchrony. Contrastingly, astrocytes and microglial cells prioritized in the depressive brain tissue exhibited genes consistent with a pro-inflammatory phenotype and impaired support for neuronal survival and plasticity.
Intriguingly, the study identified a set of “hub” genes with altered expression patterns that are common to both disorders, interfacing with known psychiatric risk loci from genome-wide association studies. These genes appear to orchestrate complex networks involving neuroinflammation, neurotransmission, and cellular metabolism, positing them as potential therapeutic targets that could modulate trajectories of mood disorder progression. Such convergence strengthens the conceptualization of mood disorders as spectrum diseases sharing overlapping pathogenic pathways.
The authors further investigated how chronic mood symptoms might imprint on gene expression by comparing early versus late-stage individuals with BD and MDD. Progressive dysregulation in synaptic and mitochondrial genes suggested a cumulative neurobiological burden, providing molecular correlates for illness chronicity and cognitive decline observed clinically. This temporal dimension paves the way for identifying early biomarkers and intervention windows before irreversible neuropathology ensues.
Advanced computational modeling and network analyses underscored the power of integrating multi-omic datasets for unraveling neuropsychiatric complexity. By employing weighted gene co-expression network analysis, the team uncovered modules heavily enriched for cell-type-specific functions altered in mood disorders. This systems biology perspective highlights how individual gene changes ripple through interconnected pathways, culminating in the multifaceted symptomatology seen in BD and MDD.
Importantly, this research leveraged well-characterized human brain samples, overcoming the limitations of animal models which frequently fail to recapitulate the full spectrum of human mood disorder biology. Postmortem studies like this bridge the translational gap, anchoring preclinical findings to human pathology and enhancing the relevance and precision of future therapeutic development.
The implications for treatment are manifold. Identifying distinct molecular signatures opens avenues for personalized medicine, enabling clinicians to tailor interventions based on an individual’s unique gene expression profile. For example, therapeutics targeting mitochondrial dysfunction may benefit BD patients exhibiting specific transcriptomic disturbances, while anti-inflammatory strategies could be prioritized for MDD cases marked by neuroimmune dysregulation.
Looking forward, the integration of single-nucleus transcriptomics with other emerging modalities—such as epigenomic mapping, spatial transcriptomics, and proteomics—promises to construct even richer cellular atlases of the human brain in health and disease. These comprehensive data layers will be instrumental in deciphering the dynamic interplay of genes, environment, and neural circuitry that culminate in complex psychiatric illnesses.
This study by Gao and colleagues represents a landmark in neuropsychiatric research by elegantly demonstrating how advanced genomic technologies can dissect heterogeneity within and between mood disorders at an unparalleled resolution. Such mechanistic insights are crucial for the rational design of next-generation therapeutics with improved efficacy and fewer side effects, addressing the considerable unmet needs in mental health care.
Beyond its scientific merit, this research challenges existing diagnostic frameworks, advocating for a biology-driven reclassification of mood disorders that transcends symptomatic overlap. As psychiatric medicine moves toward precision psychiatry, findings like these underscore the urgent imperative to redefine mental illnesses based on molecular pathology rather than solely clinical presentation.
In conclusion, by unveiling both shared and distinct transcriptomic landscapes of bipolar disorder and major depressive disorder, this landmark study illuminates the molecular intricacies underlying these enigmatic illnesses. It sets a new gold standard for postmortem brain research and opens transformative pathways toward more effective diagnostics and interventions that can profoundly improve the lives of millions suffering from mood disorders globally.
Subject of Research: Molecular and cellular abnormalities in bipolar disorder and major depressive disorder as revealed by postmortem brain single-nucleus and bulk gene expression analyses.
Article Title: Postmortem brain single-nucleus and bulk gene expression analyses identify shared and distinct abnormalities in bipolar disorder and major depressive disorder.
Article References:
Gao, R., Otsuka, I., Shirai, T. et al. Postmortem brain single-nucleus and bulk gene expression analyses identify shared and distinct abnormalities in bipolar disorder and major depressive disorder. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04200-5
Image Credits: AI Generated
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain as we age? A new study of more than 2,000 older adults in Japan found that people with lower levels of [...]Researchers developed a brain-controlled gaming system that learns from the brain’s natural wiring, enabling fast BCI training and potentially transforming medicine, mental health, and human-computer interaction. It may not be long before video game controllers become optional. Researchers at Yale University have developed a new brain-computer interface (BCI) that allows people to play video games [...]The aging brain may be far more capable of growth and improvement than scientists once believed. A large three-year study from researchers at The University of Texas at Dallas’ Center for BrainHealth (CBH) is challenging a long-standing assumption about aging. The findings suggest that mental sharpness is not destined to decline over time and that [...]Compound 10 slowed dementia-like decline in mice.Older adults with higher vitamin C levels showed stronger brain-network markers.A naturally occurring anti-inflammatory protein fragment is showing promise in early Parkinson’s disease research. Parkinson’s disease affects millions of people worldwide, yet current treatments mainly address symptoms rather than the underlying damage occurring in the brain. Now, researchers in Brazil have identified a promising new approach that targets a different aspect of the disease: inflammation. [...]A copper-based drug helped the brain flush out Alzheimer’s toxins, cutting plaque buildup and improving memory in a promising new study. Scientists at Monash University have identified a promising new approach to tackling Alzheimer’s disease. In laboratory studies, a copper-delivering drug significantly lowered levels of toxic proteins linked to the disease while also improving long-term [...]Researchers may have stumbled on a completely unknown pathway.Copper diacetyl bis(4-methyl-3-thiosemicarbazone), or Cu(ATSM), restored a key waste-removal system in the brain, reducing toxic amyloid-beta buildup and improving spatial memory in lab models of Alzheimer’s disease, according to a team of researchers at Monash University.
The post Experimental Copper-Based Drug Clears Alzheimer’s Plaques and Boosts Memory in Mice appeared first on Sci.News: Breaking Science News.
Scientists have created the first complete brain-to-body wiring map of a fruit fly, revealing that complex behavior may arise from distributed neural teamwork rather than a central controller. A large international research team led by labs at Harvard Medical School and Princeton University has reached a major neuroscience milestone: a complete wiring diagram of every [...]Scientists discovered that the brain begins preparing for social connection before we even make the first move. Why do we decide to approach other people? According to new research, the answer may start unfolding in the brain several seconds before any movement takes place. A team of scientists from the Hebrew University of Jerusalem has [...]A new study suggests that reproducing a crucial sleep-like brain pattern in awake animals may help preserve memory and learning abilities. What if part of the brain could get some of the benefits of sleep without the rest of the brain ever going offline? A new NIH-funded study suggests that may be possible. Researchers found [...]Tiny lab-grown brain models and the particles they release may reveal hidden differences among Alzheimer’s patients. Personalized treatment remains one of the biggest challenges in Alzheimer’s disease. Two patients can receive the same medication for symptoms such as depression, anxiety, or agitation and experience very different outcomes, leaving doctors with few ways to predict who [...]The study probes how flexible the dreaming body can feel.
Scientists have often wondered how the brain can take in new experiences without erasing stored memories. However, a new study in Nature now identifies a circuit-level mechanism that may help answer this question—and it may also offer clues for improving artificial intelligence.
Researchers at NYU Langone Health recorded the activity of hundreds of neurons simultaneously across several brain regions in mice. By tracking how signals move from the hippocampus to the neocortex, where long-term memories are kept, they found that a subset of hippocampal neurons appears to participate in routing information between regions in distinct patterns. These cells participate in both incoming and outgoing signaling, but do so using distinct patterns of activity.
The study focused on a series of interconnected brain regions: CA3, which processes rapidly changing information; CA1, which serves as a central hub; and the retrosplenial cortex, which is important for navigation and spatial memory. About one in four CA1 neurons receives most of the signals from CA3. When these same neurons send signals to the retrosplenial cortex, they fire in a different pattern, creating a separate outgoing channel using the same cells.
Rather than using new neurons, the brain separates these channels by changing how the same neurons fire together. The researchers suggest this arrangement may help reduce interference between new learning and more stable cortical memories.
“Our findings help explain how memory can be both moldable and enduring,” said co-lead author Joaquín Gonzalez, PhD, a postdoctoral fellow in the Department of Psychiatry at NYU Grossman School of Medicine. “By changing how the same cells fire together instead of turning on new cells, the brain can keep information organized and protect older memories.”
The CA1 neurons involved in learning during the day also stay active at night. The researchers found that these cells remain busy during sleep events called sharp-wave ripples, which are bursts of activity the hippocampus uses to replay and strengthen memories from the day.
Since overlapping neurons are recruited during both waking activity and sleep replay, the same circuit elements appear to participate in both learning and consolidation. This theoretically allows the brain to use a single system for both learning and storing memories, without the two processes interfering with each other.
“Our study shows how learning and memory consolidation can coexist in the same network,” said co-lead author Mihály Vöröslakos, MD, PhD. “Our discovery was made possible because for the first time, we were able to record hundreds of individual neurons across all the key regions simultaneously in animals that were moving around naturally.”
The system identified in this research may help explain how memory disorders begin. In Alzheimer’s disease, for example, the hippocampal circuits examined here are some of the earliest to deteriorate. These networks are essential for sorting and organizing new experiences.
“Our discovery of a ‘memory switchboard’ deep in the hippocampus may provide clues as to how memory circuits fail in Alzheimer’s disease,” said co-senior author Zhe S. Chen, PhD, a professor in the Departments of Psychiatry and Neuroscience at NYU Grossman School of Medicine.
Artificial intelligence systems have a hard time holding onto what they’ve already learned when faced with new tasks, a problem researchers call catastrophic forgetting. The human brain appears able to update memories without catastrophic forgetting by altering the use of existing neural circuits. By studying how our brains pull this off, scientists hope to design AI that can keep learning new things without forgetting the old.
“By showing how the mammalian brain can safeguard memories during learning, our research may offer a biological blueprint for designing next-generation AI technology that can update itself continuously without overwriting what it has already acquired,” said co-senior author György Buzsáki, MD, PhD, the Biggs Professor of Neuroscience at NYU Grossman School of Medicine.
The researchers plan to investigate whether similar switchboard-like channels exist in other memory circuits. The authors caution that their findings in mice under controlled conditions do not yet allow conclusions about the human brain.
Austin Burgess is a writer and researcher with a background in sales, marketing, and data analytics. He holds an MBA, a Bachelor of Science in Business Administration, and a data analytics certification. His work focuses on breaking scientific developments, with an emphasis on emerging biology, cognitive neuroscience, and archaeological discoveries.
Brain scans have uncovered two biologically distinct forms of autism hidden within the spectrum. An international team of researchers has identified at least two biologically distinct forms of autism by examining how different regions of the brain communicate with one another. The findings could help advance more precise and personalized approaches to autism care and [...]
Login